SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · Real-Time Price · USD
36.35
-0.79 (-2.13%)
Dec 27, 2024, 2:48 PM EST - Market open
SpringWorks Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SWTX stock have an average target of 67, with a low estimate of 60 and a high estimate of 74. The average target predicts an increase of 84.32% from the current stock price of 36.35.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 20, 2024.
Analyst Ratings
The average analyst rating for SWTX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $60 | Buy | Initiates | $60 | +65.06% | Nov 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $76 → $74 | Strong Buy | Maintains | $76 → $74 | +103.58% | Nov 12, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $64 → $68 | Buy | Maintains | $64 → $68 | +87.07% | Sep 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $76 | Strong Buy | Reiterates | $76 | +109.08% | Aug 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +103.58% | Jun 4, 2024 |
Financial Forecast
Revenue This Year
192.11M
from 5.45M
Increased by 3,426.90%
Revenue Next Year
362.93M
from 192.11M
Increased by 88.92%
EPS This Year
-3.16
from -5.15
EPS Next Year
-2.25
from -3.16
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 206.6M | 441.4M | 728.3M | |||
| Avg | 192.1M | 362.9M | 526.7M | |||
| Low | 162.4M | 304.3M | 296.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3,693.6% | 129.8% | 100.7% | |||
| Avg | 3,426.9% | 88.9% | 45.1% | |||
| Low | 2,882.2% | 58.4% | -18.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.07 | -1.55 | 0.15 |
| Avg | -3.16 | -2.25 | -1.55 |
| Low | -3.16 | -3.25 | -2.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.